INSURANCE REGULATORY AND DEVELOPMENT AUTHORITY OF INDIA Ref. No:IRDAI/HLT/REG/CIR/199/07/2020 Date:24-07-2020 To All Insurance Companies and Third Party Administrators Re: Extension of timelines to comply with the Standards and Benchmarks for the Hospitals in the Provider Network 1. Reference is invited to Chapter IV of the Guidelines on Standardization in Health Insurance under Section 1 of […]
On a review, it has been decided that the unrealised gain/loss on a derivative transaction undertaken for hedging may be offset against the unrealised loss/gain recognized in the capital (either through Profit or Loss or through Other Comprehensive Income) on the corresponding underlying hedged instrument.
Reporting to Stock Exchanges regarding violations under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 relating to the Code of Conduct (CoC).
It has been decided that in addition to the transactions mentioned in Clause 4 (3) (b) of Schedule B read with Regulation 9 of PIT Regulations, trading window restrictions shall not apply in respect of OFS and RE transactions carried out in accordance with the framework specified by the Board from time to time.
Specified person for this purpose has been defined to mean wholly owned subsidiaries of Abu Dhabi Investment Authority (ADIA), notified Sovereign Wealth Fund (SWF) and notified Pension Funds (PF), which fulfil conditions specified in the clause or to be prescribed for the PF.
In order to enhance the transparency and disclosure pertaining to debt schemes and investments by mutual funds in Corporate Bonds/Commercial Papers, SEBI based on the recommendation of Mutual Fund Advisory Committee (MFAC) has decided the following:
Insurance Regulatory and Development Authority of India Ref: IRDAI/HLT/REG/CIR/194/07/2020 22nd July, 2020 All Insurers (excluding specialized insurers) and TPAs, wherever applicable Sub: Consolidated Guidelines on Product filing in Health Insurance Business 1. Objective: 1.1 The extant IRDAI (Health Insurance) Regulations 2016 were notified on 18th July, 2016 superseding IRDA (Health Insurance) Regulations 2013. 1.2 The […]
The disclosure to the Stock Exchange(s) shall be made by listed entities on quarterly basis along with the declaration of financial results (within 45 days of end of each quarter / 60 days from the end of the last quarter of the financial year) until such funds are fully utilized or the purpose for which these proceeds were raised has been achieved.
While calculating the residual losses as per ‘d’ and ‘f’ above, for positions on which early pay-in are given by the clients/brokers, and margin exemption are granted on such positions, CCs are permitted to consider the ‘margin exemption granted’ or ‘value of early paid-in goods’, whichever is lower, as ‘margins supporting those positions
All the general and health insurance companies (insurers) were mandated to offer Individual Covid Standard Health product, Corona Kavach Policy. Insurers are hereby allowed to offer Corona Kavach Policy as group product by duly complying with the norms specified.
